FORA Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,064
Closed -$5.56M 540
2024
Q4
$5.56M Buy
15,064
+14,430
+2,276% +$6.04M 0.64% 47
2024
Q3
$330K Sell
634
-3,114
-83% -$1.66M 0.04% 348
2024
Q2
$2.03M Sell
3,748
-18,938
-83% -$10M 0.25% 130
2024
Q1
$11.8M Buy
22,686
+6,229
+38% +$3.1M 0.97% 23
2023
Q4
$7.76M Sell
16,457
-3,604
-18% -$1.67M 0.67% 41
2023
Q3
$8.73M Buy
20,061
+11,283
+129% +$5.12M 0.77% 30
2023
Q2
$3.9M Buy
8,778
+3,004
+52% +$1.39M 0.55% 52
2023
Q1
$2.65M Sell
5,774
-4,609
-44% -$2.19M 0.27% 114
2022
Q4
$5.33M Buy
10,383
+7,730
+291% +$3.92M 0.86% 21
2022
Q3
$1.21M Buy
+2,653
New +$1.27M 0.23% 135
2022
Q2
Sell
-3,224
Closed -$1.62M 497
2022
Q1
$1.62M Buy
3,224
+1,923
+148% +$879K 0.29% 105
2021
Q4
$603K Buy
+1,301
New +$547K 0.23% 127
2021
Q1
Sell
-3,909
Closed -$1.25M 865
2020
Q4
$1.25M Buy
+3,909
New +$1.2M 0.19% 122
2020
Q3
Sell
-368
Closed -$97K 735
2020
Q2
$97K Buy
+368
New +$98.2K 0.03% 501

Other funds holding ELV

FORA Capital's ELV Position: Q1 2025 in Review

FORA Capital sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 15,064 shares — an estimated $5.56M sold.

FORA Capital first reported a position in ELV in Q2 2020 and held it in 14 quarters. The position peaked at $11.8M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • FORA Capital reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • FORA Capital sold 15,064 Elevance Health shares in Q1 2025, an estimated $5.56M.
  • FORA Capital first reported a position in Elevance Health in Q2 2020 and held it in 14 quarters.
  • FORA Capital's Elevance Health position peaked at $11.8M in Q1 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on FORA Capital's 13F filing for Q1 2025, filed 14 May 2025.